LRMR

Larimar TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

LRMR vs peer average

40/100

LRMR vs. peer average (D vs. C)

Grade spread

A 1 · B 2 · C 2 · D 4 · F 2

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

FHTX is the first available peer comparator.

Loose peer: clinical-stage biotech with event-driven re-rating risk and dependence on capital markets, useful mainly for comparing binary milestone sensitivity rather than disease overlap.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerFHTXFoghorn Therapeutics

LRMR

Larimar Therapeutics

FHTX

Foghorn Therapeutics

Grade

Momentum

Value

Sentiment

100

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs FHTX

LRMR / FHTX

Grade Position

Below peers

LRMR vs. peer average (D vs. C)

40/100

Momentum

FHTX

Value

LRMR

Sentiment

100

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs LRMR

FHTX

60/100

-1

TARA

40/100

Even

ACHV

100/100

-3

PBYI

Puma Biotechnology Inc Common

80/100

-2

VSTM

Verastem Inc Common

40/100

Even

FHTX is the first peer returned for this comparison set.